Cited by 169Amyotrophic Lateral Sclerosis ResearchRNA Research and SplicingAlzheimer's disease research and treatments

Misregulated RNA processing in amyotrophic lateral sclerosis

Open access
Polymenidou, Magdalini, Lagier-Tourenne, Clotilde, Hutt, Kasey R., Bennett, C. Frank, Cleveland, Don W., Yeo, Gene W.·2012·Brain Research

Abstract

Amyotrophic lateral sclerosis (ALS) research is undergoing an era of unprecedented discoveries with the identification of new genes as major genetic causes of this disease. These discoveries reinforce the genetic, clinical and pathological overlap between ALS and frontotemporal lobar degeneration (FTLD). Common causes of these diseases include mutations in the RNA/DNA-binding proteins, TDP-43 and FUS/TLS and most recently, hexanucleotide expansions in the C9orf72 gene, discoveries that highlight the overlapping pathogenic mechanisms that trigger ALS and FTLD. TDP-43 and FUS/TLS, both of which participate in several steps of RNA processing, are abnormally aggregated and mislocalized in ALS and FTLD, while the expansion in the C9orf72 pre-mRNA strongly suggests sequestration of one or more RNA binding proteins in pathologic RNA foci. Hence, ALS and FTLD converge in pathogenic pathways disrupting the regulation of RNA processing. This article is part of a Special Issue entitled RNA-Binding Proteins.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.brainres.2012.02.059

Cites

161 of 161 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Disease changes can affect the activity or expression of RNA binding proteins, causing entire programs of alternative splicing to be misregulated.

    “Other disease changes affect the activity or expression of RBPs, causing entire programs of AS to be misregulated.”

    From A Highly Conserved Program of Neuronal Microexons Is Misregulated in Autistic Brains (2014) · cites this paper as Polymenidou et al., 2012

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Polymenidou, M., Lagier-Tourenne, C., Hutt, K. R., Bennett, C. F., Cleveland, D. W., & Yeo, G. W.
Affiliations
  • University of California San Diego (US)
  • Ionis Pharmaceuticals (United States) (US)
Corresponding author
  • Cleveland, Don W.
  • Yeo, Gene W.
Venue
Brain Research
Publisher
Elsevier BV
Published
2012-06
Volume
1462
Pages
3-15
ISSN
0006-8993 (ISSN-L)
OpenAlex
W2045708478
Cited by
169
References
161
Citations by year
2026: 5 · 2025: 4 · 2024: 4 · 2023: 9 · 2022: 7 · 2021: 14 · 2020: 22 · 2019: 7 · 2018: 8 · 2017: 15 · 2016: 13 · 2015: 13 · 2014: 21 · 2013: 18 · 2012: 9
FWCI
2.73
Type
journal article
Language
en
Open access
Locations
  • Brain Research (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • Human Frontier Science Program Organization
  • Amyotrophic Lateral Sclerosis Association
  • Muscular Dystrophy Association
  • National Institute of Neurological Disorders and Stroke (K99NS075216, R37NS27036)
  • National Institutes of Health (HG004659, GM084317)
  • California Institute for Regenerative Medicine (RB1-01413)
  • University of California, San Diego
Topics
  • Health Sciences › Medicine › Neurology › Amyotrophic Lateral Sclerosis Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Research and Splicing
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
Keywords
amyotrophic lateral sclerosis, frontotemporal lobar degeneration, RNA processing, TDP-43, FUS/TLS, C9orf72 repeat expansion, RNA-binding proteins, protein aggregation, RNA foci, pre-mRNA
MeSH terms
Amyotrophic Lateral Sclerosis, Animals, DNA-Binding Proteins, Homeostasis, Humans, RNA, RNA-Binding Proteins, RNA-Binding Protein FUS, Frontotemporal Lobar Degeneration, TDP-43 Proteinopathies

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review